System Inventory
Application inventory establishes what the target actually runs, which frequently differs from what IT leadership describes or documentation shows.
Custom Software
Healthcare M&A Technology Due Diligence
EHR consolidation is routinely the largest unbudgeted cost in a healthcare acquisition, and it is frequently estimated by people who have never done one. A migration described as eighteen months in a deal model can take three years in practice, and the gap is not a variance. It changes whether the transaction produced the value the thesis assumed.
Technology diligence in healthcare carries risks other sectors do not: clinical system dependency, regulated data, and integration timelines measured in years. Taction Software delivers healthcare M&A technology due diligence grounded in what consolidation actually costs rather than what a target’s IT leadership hopes.
Tell Us Your Requirements
Our experts are ready to understand your business goals.
Trusted Partners
Trusted by Industry Leaders Worldwide
Recognition
Awards & Recognitions
What Is Healthcare M&A Technology Due Diligence
Healthcare M&A technology due diligence assesses a target’s technology position before a transaction closes: clinical and business system inventory, EHR platform and consolidation implications, integration architecture and data quality, cybersecurity posture and incident history, regulatory and compliance technology obligations, technical debt, contracts and licensing, and realistic integration cost and timeline. It informs valuation and post-close planning. Our work sits within our broader healthcare software development practice.
EHR Consolidation Assessment
EHR position drives the largest integration decisions, since consolidating clinical platforms is expensive, slow, and clinically disruptive.
Integration and Data Quality
Data assessment covers interfaces and quality, drawing on our health data exchange work on integration realities.
Security Posture Review
Cybersecurity assessment covers controls and incident history, since acquired breaches and unremediated exposure transfer with the entity.
Compliance Technology
Regulatory systems including privacy and quality reporting are assessed, connecting with our HIPAA compliance software development practice.
Integration Cost Modeling
Cost estimation produces defensible integration figures, which is the deliverable most directly affecting the transaction model.
Core Due Diligence Services
Our healthcare M&A technology due diligence services cover inventory, clinical platform assessment, security review, contract analysis, and integration modeling. The finding that most often changes a deal is EHR consolidation cost and timeline, since acquirers frequently model it on vendor estimates rather than on comparable migrations. Engagements typically open by establishing what the acquisition thesis assumes about technology so diligence can test those assumptions specifically.
01
Thesis Assumption Testing
Assumption review identifies what the deal model assumes technically, since diligence should test the thesis rather than produce a general assessment.
02
Clinical System Assessment
EHR and clinical platform review covers version, customization, and support position, all of which affect consolidation feasibility.
03
Infrastructure and Security
Technical assessment covers infrastructure, access management, and security posture, including whether prior incidents were properly remediated.
04
Contract and Licensing Review
Agreement analysis identifies change of control provisions and licensing that may reprice or terminate on transaction.
05
Technical Debt Quantification
Debt assessment identifies deferred work that will require investment, which is frequently substantial in organizations under financial pressure.
06
Integration Planning
Post-close planning produces sequencing and cost, connecting with our healthcare software development company delivery experience.
Benefits of Technology Due Diligence
The benefits concentrate in accurate integration cost, identified risk, and executable post-close planning. Technology cost surprises after close are difficult to recover from, since the acquirer owns the problem and the price was already paid. We publish no figures on cost avoidance or deal outcomes, because those depend entirely on the specific transaction and what diligence found.
Realistic Integration Cost
Defensible estimates replace vendor optimism, which is the single largest source of post-close technology budget failure in healthcare acquisitions.
Identified Security Exposure
Posture assessment surfaces unremediated incidents and control gaps before they become the acquirer’s liability.
Contract Risk Visibility
Change of control provisions surface before close, when they can still affect price or structure rather than arriving as a surprise invoice.
Clinical Disruption Awareness
Consolidation assessment identifies clinical disruption risk, which affects retention of the clinicians the acquisition was frequently intended to acquire.
Executable Post-Close Plan
Integration sequencing gives the acquirer a plan on day one rather than beginning assessment after the transaction has closed.
Informed Valuation
Technology findings inform price and structure, which is the point of doing diligence before rather than after signing.
Our Due Diligence Process
We deliver healthcare M&A technology due diligence on transaction timelines, which are short and non-negotiable. Discovery begins with the acquisition thesis, since diligence that tests deal assumptions is more useful than a comprehensive assessment delivered after the decision. Access is frequently limited in competitive processes, so we structure findings around what can be established with available access and state confidence levels explicitly.
Thesis and Scope Definition
Scope begins with deal assumptions, since testing the thesis matters more than comprehensive assessment when time is constrained.
Data Room and Interview Review
Available materials and management interviews establish the documented position, which we then test rather than accept.
Technical Assessment
Hands-on review where access permits covers systems, infrastructure, and security, since documentation frequently overstates the actual position.
Cost Modeling
Integration estimation is built from comparable work rather than target or vendor estimates, which are systematically optimistic.
Risk Rating
Findings are rated by materiality to the thesis, with confidence stated since limited access constrains what can be established.
Post-Close Planning
Day one planning converts findings into sequenced integration work if the transaction proceeds.
Technology and Compliance
Due diligence involves access to a target’s systems and data under confidentiality constraints, with care required around protected health information. Taction holds ISO 27001 certification and follows HIPAA-aligned engineering practice. Diligence access should avoid exposure to patient data where assessment can be performed without it, since acquirers reviewing PHI before close creates obligations and complications that add nothing to the assessment.
PHI Access Limits
Assessment approach avoids patient data where possible, since pre-close exposure creates obligations without improving technical findings.
Confidentiality Obligations
Deal confidentiality governs findings handling, with access controls appropriate to material non-public information about both parties.
Security Findings Sensitivity
Vulnerability findings require careful handling, since documentation of a target’s exposure is itself sensitive if the deal does not proceed.
Regulatory Obligation Transfer
Compliance position transfers with the entity, so unremediated regulatory exposure becomes the acquirer’s problem at close.
Contract Assignment
Licensing and agreements may not transfer or may reprice, which is a technology cost question with legal dependencies.
Assessment Documentation
Findings are documented with stated confidence, since limited access means some conclusions are inference rather than verification.
Why Choose Taction Software
Taction Software was founded in 2013 and has spent over 12 years building healthcare software, delivering more than 200 healthcare projects from four US offices in Chicago, Cheyenne, Austin, and Sacramento, with ISO 27001 certification. Our relevant qualification is that we do the integration work afterward, which means our cost estimates reflect what delivery actually involves rather than what a diligence framework suggests. Our leadership brings more than 20 years of personal experience in the field.
01
Estimates From Delivery Experience
We estimate integration cost from work we have done, rather than from frameworks that systematically understate healthcare migration timelines.
02
Thesis-Focused Diligence
We test deal assumptions rather than producing comprehensive assessment, since transaction timelines do not accommodate both.
03
Confidence Stated
We state confidence levels, since limited diligence access means some findings are inference and presenting them otherwise misleads.
04
Established Healthcare Focus
Founded in 2013, we have concentrated on healthcare rather than treating it as one vertical among several, producing depth in clinical systems.
05
Clinical Disruption Awareness
We assess clinical impact of consolidation, since disruption affects clinician retention and therefore the value the acquisition assumed.
06
Certified Security Posture
ISO 27001 certification means security controls are documented and auditable, which matters when handling deal-sensitive material.
Pricing
Healthcare M&A technology due diligence pricing depends on target complexity, access level, timeline compression, and whether post-close planning is included. Compressed timelines carry a premium, since transaction schedules require concentrated effort rather than sequential work. Discovery produces a scoped estimate quickly, given that diligence engagements begin under time pressure. Travel and third-party assessment costs are separate and itemized clearly.
MVP or Single Module
A focused assessment covering a single target with defined scope typically runs $40,000 to $80,000.
Full Platform Build
A full diligence engagement with integration cost modeling and post-close planning typically falls between $80,000 and $200,000.
Enterprise Deployment
Enterprise engagements covering multi-entity transactions or platform acquisitions start at $200,000.
Discovery Phase Scoping
Scoping is rapid given transaction timelines, producing an itemized estimate and assessment plan within days rather than weeks.
Cost Drivers to Expect
Target complexity, access level, timeline compression, and entity count are the largest variables, established during scoping.
Ongoing Support Costs
Post-close integration delivery is quoted separately, since diligence and execution are distinct engagements with different scopes.
Get Started
If you are evaluating healthcare M&A technology due diligence for a transaction in progress, the fastest next step is a call with our team. We work on transaction timelines and will scope an assessment against your deal thesis within days. Contact us to schedule that conversation.
FAQs
Frequently Asked Questions
Corporate development and private equity leaders evaluating healthcare M&A technology due diligence usually ask about EHR consolidation cost, timeline realism, and what limited access permits. The answers below reflect how we scope these engagements.
Because it is estimated from vendor guidance rather than comparable migrations, and because clinical disruption and data migration effort are systematically underestimated. A timeline described as eighteen months frequently runs considerably longer, which changes the transaction model rather than merely the project plan.
Substantially more than nothing, and less than full access permits. We state confidence levels explicitly, distinguishing verified findings from inference based on documentation and interviews. Presenting inference as verification is how diligence misleads acquirers.
Generally no. Technical assessment rarely requires it, and pre-close exposure to protected health information creates obligations without improving findings. We design assessment approaches that avoid it where the questions can be answered otherwise.
A focused assessment runs $40,000 to $80,000. Full diligence with integration modeling typically falls between $80,000 and $200,000. Multi-entity transactions start at $200,000. Access level and timeline compression drive cost most.
We can, and we scope it separately. The relevant point for diligence is that our estimates come from having done this work, which is why they tend to be larger and more accurate than estimates produced by firms that only assess.
EHR consolidation cost and timeline, unremediated security exposure, and change of control provisions that reprice critical contracts. All three are quantifiable before close and expensive to discover afterward.